Health-economic modelling to inform private sector investment in infectious disease treatments in middle-income countries: The case of tuberculosis

No Thumbnail Available
File version
Author(s)
Steuten, L
Garau, M
Gomez, G
Arinaminpathy, N
Vassall, A
Chalkidou, K
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2019
Size
File type(s)
Location

Copenhagen, Denmark

License
Abstract

Progress in developing of better infectious disease treatments in middle-income countries is slow, creating a need to incentivize increased private sector investment. The Bill & Melinda Gates Foundation (BMGF) commissioned the development of a health-economic model for measuring, aggregating, monetizing, and securitizing future middle-income country demand for better tuberculosis (TB) treatments, and stimulate research and development (R&D).

Journal Title
Conference Title

VALUE IN HEALTH

Book Title
Edition
Volume

22

Issue

Supplement 3

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Applied economics

Social Sciences

Science & Technology

Life Sciences & Biomedicine

Economics

Health Care Sciences & Services

Persistent link to this record
Citation

Steuten, L; Garau, M; Gomez, G; Arinaminpathy, N; Vassall, A; Chalkidou, K, Health-economic modelling to inform private sector investment in infectious disease treatments in middle-income countries: The case of tuberculosis, Value in Health, 2019, 22, pp. S209-S209